2026 Q3 Portfolio Activity
In 2026 Q3, Merck & Co., Inc. maintained a portfolio of 13 distinct positions.
Position History
hover any row below to update
Loading…
Merck & Co., Inc.
AUM $820M
Total Positions
13
Quarter
2026 Q3
Top Holding
MRNA (54.2%)
Top 10 Concentration
99.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13
Merck & Co., Inc. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MRNA
MODERNA INC
|
Healthcare | 54.18% | 30.71% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
2,308,190 | $444,488,148 |
$41.58
+379.4%
|
2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
PSNL
PERSONALIS INC
|
Healthcare | 27.87% | 35.75% |
#2
1
Prev: #1
|
6.5 |
—
|
no change | no change |
P
S
|
14,044,943 | $228,651,672 |
$5.78
+146.9%
|
2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 10.52% | 16.82% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
772,165 | $86,320,325 |
$40.23
+186.6%
|
2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
AKTS
AKTIS ONCOLOGY ...
|
Healthcare | 2.26% | 5.83% |
#4
Prev: #4
|
2.4 |
—
|
no change | no change |
P
S
|
952,844 | $18,551,873 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EIKN
EIKON THERAPEUT...
|
Healthcare | 1.63% | 4.13% |
#5
Prev: #5
|
2.2 |
—
|
no change | no change |
P
S
|
1,666,666 | $13,399,995 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 1.35% | 2.43% |
#6
Prev: #6
|
1.5 |
—
|
no change | no change |
P
S
|
1,739,768 | $11,047,527 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.80% | 1.35% |
#7
1
Prev: #8
|
1.3 |
—
|
no change | no change |
P
S
|
3,545,719 | $6,559,581 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.53% | 1.72% |
#8
1
Prev: #7
|
1.2 |
—
|
no change | no change |
P
S
|
272,351 | $4,387,575 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EVAX
EVAXION AS
|
Healthcare | 0.49% | 0.71% |
#9
Prev: #9
|
1.2 |
—
|
no change | no change |
P
S
|
1,214,126 | $3,982,333 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.23% | 0.33% |
#10
Prev: #10
|
1.1 |
—
|
no change | no change |
P
S
|
93,414 | $1,923,394 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
XLO
XILIO THERAPEUT...
|
Healthcare | 0.12% | 0.19% |
#11
Prev: #11
|
1.0 |
—
|
no change | no change |
P
S
|
105,982 | $959,137 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HURA
TUHURA BIOSCIEN...
|
Healthcare | 0.00% | 0.01% |
#12
Prev: #12
|
1.0 |
—
|
no change | no change |
P
S
|
19,445 | $40,834 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NEUP
NEUPHORIA THERA...
|
Healthcare | 0.00% | 0.01% |
#13
Prev: #13
|
1.0 |
—
|
no change | no change |
P
S
|
10,027 | $35,696 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-13 of 13 holdings